Press Releases

UC Irvine Leadership Takes Medical Education to the Next Level by Integrating an Innovative Ultrasound Program and Curriculum BOTHELL, WA - August 11, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, and the University of California, Irvine, announced today that the company and institution have signed an agreement to integrate ultrasound visualization into UC Irvine's four-year medical school curriculum.

Under the terms of this agreement, SonoSite will act as an exclusive ultrasound partner. The collaborative efforts of both UC Irvine and SonoSite will provide medical students with an active and dynamic learning experience that will transform traditional teaching methods used during medical school training. SonoSite's ultrasound systems will enable students to view anatomical structures in real-time and better understand physiological processes. This innovative ultrasound curriculum is setting the standard for other leading medical institutions and providing UC Irvine's students with the skill set and tools to improve medicine.

BOTHELL, WA - August 10, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside ultrasound for the point-of-care, today announced the retirement of Mike Schuh as Chief Financial Officer. Marcus Smith has been appointed as Senior Vice President and Chief Financial Officer and will replace Mr. Schuh as he retires from his position.

"I'm incredibly fortunate to have worked with such a visionary company and dedicated leadership team over the last ten years," said Mike Schuh. "SonoSite is truly transforming medicine and will continue to make significant contributions to the healthcare industry with its innovative technology and passionate culture that is focused on improving medicine."

"I want to thank Mike for his many contributions and ten years of dedication, hard work, and excellent service," said Kevin M. Goodwin, SonoSite's President and CEO. "Mike has been instrumental in establishing a successful financial infrastructure and serving as a trusted advisor. We wish him the best of luck in retirement."

A key member of SonoSite's executive team, Mr. Smith joined the company in 2007 as Vice President of Corporate Strategy and Growth Planning. He has since led the successful acquisition of SonoSite's primary care business while he served as SonoSite's Vice President and General Manager of Cardiovascular Disease Management.

Revenue Rises 18% EBIT Increases 145%, Excluding Acquisition Charges Gross Margins Rise to 72% Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern BOTHELL, WA - July 26, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today reported financial results for the second quarter and first half ended June 30, 2010.

REVENUE Revenue increased 18% in the second quarter to $61.5 million and 13% for the first half of 2010 to $117.5 million, as compared to the prior year comparable periods. These comparisons included revenue of $3.8 million for the quarter and $7.0 million for the first half of 2010 from CardioDynamics (CDIC), which was acquired in the third quarter of 2009. SECOND QUARTER HIGHLIGHTS:

Revenue growth was led by SonoSite's US hospital channel, which was up 20%. Revenue from the international business was impacted by a slowdown in Europe. The Company had steady performances in several other international markets and was up 2%. The International business sector profitability grew 7-8 times the "top line" growth rate, despite the slower revenue. Pricing discipline and an improved product mix led to a 1.4 percentage point increase in gross margins to 72% for the quarter. The Company had strong performances across all four vertical clinical markets.

EBIT and EBITDAS Second Quarter

Major Advancement for Regional Nerve Blocks and Other Injection Based Procedures Highly Advanced Algorithms Were Developed Over Two Years and Aimed at Solving the Disappearing Needle Phenomenon in Anesthesia BOTHELL, WA - July 13, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today introduced Enhanced Needle Visualization, a significant development in ultrasound imaging that enables improved needle tracking with increased confidence during deep needle procedures. Enhanced Needle Visualization is a proprietary imaging technology that intensifies the brightness of the needle, making it clearly visible during a steep angle approach to a deep target, conditions under which the needle has previously been difficult to image. Enhanced Needle Visualization is now available as a software upgrade for SonoSite's M-Turbo® and S Series™ ultrasound product lines.

SonoSite's Enhanced Needle Visualization technology is the first fully-integrated solution to resolve the "lost needle phenomenon,"1which has been an...

BOTHELL, WA - July 8, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it will report the company's second quarter financial results on Monday, July 26, 2010 at the close of market and will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on that day. The call will be broadcast live and can be accessed via SonoSite's website at www.sonosite.com/investorinformation/webcasts .

A replay of the audio webcast will be available beginning July 26, 2010 at 5:30 p.m. PT and can be accessed until August 9, 2010 at 9:59 p.m. PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 2747293 is required to access the replay. Additionally, the call will be archived on SonoSite's website.

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

BOTHELL, WA - June 30, 2010 - SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that on June 30, 2010, it completed its acquisition of privately held VisualSonics , a Toronto-based company focused on ultra high-frequency micro-ultrasound technology, for $67.9 million net of cash and debt.

“This acquisition positions SonoSite for long-term growth in the pre-clinical and clinical point-of-care markets and enables the creation of potential breakthrough imaging products for both market spaces,” said Kevin M. Goodwin, SonoSite President and CEO. “With unmatched ultra high-frequency technology, which operates at five times the center frequency of a conventional ultrasound, VisualSonics’ micro-imaging technology has the potential to revolutionize clinical medicine and continue to transform pre-clinical research.”

“We are pleased to finalize this agreement with SonoSite,” said Anil Amlani, VisualSonics’ President and CEO. “SonoSite and VisualSonics share a passion for creating innovative products and driving new market opportunities.”

Under the terms of the agreement, VisualSonics will become a wholly-owned subsidiary of SonoSite, Inc. Shareholders of VisualSonics approved the acquisition.

About VisualSonics

BOTHELL, WA - June 29, 2010 - SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that the Company plans to host its second annual Analyst Day. The meeting will be held on Thursday, August 12, 2010, at the company’s headquarters in Bothell.

The Analyst Day offers SonoSite institutional and mutual fund investors the opportunity to hear from key members of SonoSite’s leadership team and learn more about the Company’s recent acquisition of VisualSonics. The agenda will also include a Q&A session with select members of the executive team.

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound and industry leader in impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight ultrasound systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

UMI to Serve as a Distributor for SonoSite Products into Private Medical Offices

BOTHELL, WA - June 22 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound and United Medical Instruments (UMI), a worldwide provider of new and pre-owned ultrasound systems, today announced a new agreement for UMI to distribute SonoSite's products into certain small office markets. Under this relationship, UMI will act as an additional distributor of SonoSite's flagship M-Turbo® and MicroMaxx® ultrasound systems and will serve as a re-seller of SonoSite's used products from its older lines. This collaboration strongly positions SonoSite to continue to expand its presence in the office markets, while offering physicians greater access and customer support.

SonoSite's point-of-care ultrasound systems are designed to provide healthcare professionals with the ability to view anatomy in a greater variety of clinical settings. With the implementation of real-time visualization, physicians in office settings are able to confidently assess, diagnose and perform interventional procedures directly in the patient's examination room.

BOTHELL, WA - June 11, 2010 – SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced a stock repurchase program under which the company may purchase up to $50 million of its common stock over the next twelve months. Since February 2010, SonoSite has repurchased a total of approximately 3 million shares of its common stock through a modified “Dutch Auction” tender offer at a total cost of $88.8 million.

SonoSite may repurchase its common stock from time to time, in amounts, at prices and at such times as it deems appropriate, all subject to market conditions and other considerations. SonoSite may make repurchases in the open market, in privately negotiated transactions, accelerated repurchase programs or in structured share repurchase programs. The repurchases will be conducted in compliance with the SEC’s Rule 10b-18 and applicable legal requirements and shall be subject to market conditions and other factors.

The company also expects to establish Rule 10b5-1 trading plans from time to time to effect such purchases when appropriate. The program does not obligate SonoSite to acquire any particular amount of common stock and the program may be modified or suspended at any time at the company’s discretion. Any repurchases would be funded from available cash on hand. As of March 31, 2010, SonoSite had approximately $178 million in cash, cash equivalents and short-term investment securities.

About SonoSite, Inc.

BOTHELL, WA – June 2, 2010 - SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, President and CEO, will present at the Jefferies 2010 Global Life Sciences Conference being held at the Grand Hyatt Hotel in New York City, June 8 – 11, 2010. Mr. Goodwin’s presentation will be webcast live on June 11, 2010 at 8:00 a.m. Eastern Time. An audio replay will be available for 30 days following and can be accessed via SonoSite’s website at www.sonosite.com/investorinformation/webcasts . About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound and industry leader in impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight ultrasound systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.